{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:18:30Z","timestamp":1775582310390,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.brainres.2012.11.043","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T22:41:47Z","timestamp":1354401707000},"page":"1-14","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration"],"prefix":"10.1016","volume":"1497","author":[{"given":"Ki Sung","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Yamabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2012.11.043_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesia and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2012.11.043_bib2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/tx700174w","article-title":"Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases","volume":"20","author":"Bai","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.brainres.2012.11.043_bib3","first-page":"407","article-title":"Decarboxylase inhibitors","volume":"21","author":"Bartholini","year":"1975","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2012.11.043_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00702-003-0004-z","article-title":"Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease","volume":"110","author":"Blandini","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2012.11.043_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","article-title":"Parkinson's disease is associated with hippocampal atrophy","volume":"18","author":"Camicioli","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2012.11.043_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/0049825031000108315","article-title":"Bioavailability of dietary doses of 3H-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat","volume":"33","author":"Catterall","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.brainres.2012.11.043_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00002826-199108000-00005","article-title":"Reduction of circulating 3-O-methyldopa by inhibition of catechol-O-methyltransferase with OR-611 and OR-462 in Cynomolgus monkeys: implications for the treatment of Parkinson\u2019s disease","volume":"14","author":"Cedarbaum","year":"1991","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib9","first-page":"1045","article-title":"Absorption, distribution, elimination of tea polyphenols in rats","volume":"25","author":"Chen","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.brainres.2012.11.043_bib10","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.bcp.2005.01.024","article-title":"Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies","volume":"69","author":"Chen","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1476-5381.2010.01041.x","article-title":"Critical role of the JNK-p53-GADD45\u03b1 apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons","volume":"162","author":"Choi","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","article-title":"Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat","volume":"26","author":"Colpaert","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2012.11.043_bib13","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/brain\/aws101","article-title":"Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease","volume":"135","author":"Costa","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2012.11.043_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/BF01946641","article-title":"The pharmacology of Parkinson's disease: basic aspects and recent advances","volume":"40","author":"Da Prada","year":"1984","journal-title":"Experientia"},{"key":"10.1016\/j.brainres.2012.11.043_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjp.0703105","article-title":"The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat","volume":"129","author":"Dawson","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-4328(03)00183-9","article-title":"The role of dopamine in learning, memory, and performance of a water escape task","volume":"148","author":"Denenberg","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2012.11.043_bib17","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/jn\/129.9.1662","article-title":"Catechin is present as metabolites in human plasma after consumption of red wine","volume":"129","author":"Donovan","year":"1999","journal-title":"J. Nutr."},{"key":"10.1016\/j.brainres.2012.11.043_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/FBP.0b013e32833e7e80","article-title":"Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat","volume":"21","author":"Eskow Jaunarajs","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-211-33328-0_1","article-title":"Levodopa in the treatment of Parkinson's disease","volume":"71","author":"Fahn","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2012.11.043_bib20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1096\/fasebj.11.14.9409550","article-title":"Melatonin maintains glutathione homeostasis in kainic acid\u2014exposed rat brain tissues","volume":"11","author":"Floreani","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2012.11.043_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2009-1135","article-title":"Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease","volume":"18","author":"Ferruzzi","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2012.11.043_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0404.1977.tb01456.x","article-title":"Plasma O-methyldopa in levodopa-induced dyskinesias. A bioclinical investigation","volume":"56","author":"Feuerstein","year":"1977","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.brainres.2012.11.043_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.06.059","article-title":"Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells","volume":"617","author":"Fukui","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib150","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.freeradbiomed.2010.06.002","article-title":"Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death","volume":"4","author":"Fukui","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.brainres.2012.11.043_bib25","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/j.1460-9568.2004.03770.x","article-title":"Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor","volume":"20","author":"Georgievska","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2012.11.043_bib27","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-kappaB activation by reactive oxygen species: fifteen years later","volume":"72","author":"Gloire","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib28","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1212\/WNL.50.5_Suppl_5.S26","article-title":"Influence of COMT inhibition on levodopa pharmacology and therapy","volume":"50","author":"Goetz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2012.11.043_bib29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/01.jnen.0000225906.82428.69","article-title":"Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury","volume":"65","author":"He","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2012.11.043_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00002826-200105000-00006","article-title":"The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease","volume":"24","author":"Heikkinen","year":"2001","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2125.2002.01654.x","article-title":"Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa\/carbidopa dose","volume":"54","author":"Heikkinen","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib32","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.21706","article-title":"Coffee and tea consumption and the risk of Parkinson's disease","volume":"22","author":"Hu","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2012.11.043_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/brain\/awl332","article-title":"The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea","volume":"130","author":"Huot","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2012.11.043_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1471-4159.1993.tb05831.x","article-title":"Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum","volume":"60","author":"Kaakkola","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2012.11.043_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2008.02.011","article-title":"Smoking and tea consumption delay onset of Parkinson's disease","volume":"15","author":"Kandinov","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2012.11.043_bib36","doi-asserted-by":"crossref","first-page":"e11951","DOI":"10.1371\/journal.pone.0011951","article-title":"Dual beneficial effects of (\u2212)-epigallocatechin gallate on levodopa methylation and hippocampal neurodegeneration: In vitro and in vivo studies","volume":"5","author":"Kang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2012.11.043_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jchromb.2006.03.027","article-title":"Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levedopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid","volume":"836","author":"Karimi","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.brainres.2012.11.043_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00002826-199304000-00007","article-title":"The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers","volume":"16","author":"Ker\u00e4nen","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.53.5.1012","article-title":"Immediate-release and controlled-release carbidopa\/levodopa in PD: a 5 year randomized multicenter study","volume":"53","author":"Koller","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2012.11.043_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2009.08.013","article-title":"Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection","volume":"80","author":"Leaver","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2012.11.043_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11064-007-9442-6","article-title":"The role of 3-O-methyldopa in the side effects of L-DOPA","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2012.11.043_bib43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/ajcn\/88.4.1018","article-title":"Pure dietary flavonoids quercetin and (\u2212)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men","volume":"88","author":"Loke","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.brainres.2012.11.043_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/dmd.31.5.572","article-title":"Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (\u2212)-epigallocatechin gallate","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.brainres.2012.11.043_bib45","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0891-5849(99)00159-8","article-title":"Comparison of the bioavailability of quercetin and catechin in rats","volume":"27","author":"Manach","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2012.11.043_bib46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0031-6997(24)01423-6","article-title":"Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology and clinical efficacy of the new selective COMT inhibitors","volume":"51","author":"Mannisto","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2012.11.043_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002210050616","article-title":"Kainic acid-induced activation of nuclear factor-kB in rat hippocampus","volume":"124","author":"Matsuoka","year":"1999","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.brainres.2012.11.043_bib48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1289\/ehp.99107773","article-title":"Medicinal herbs in the United States: research needs","volume":"107","author":"Matthews","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.brainres.2012.11.043_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bdd.605","article-title":"Quercetin pharmacokinetics in humans","volume":"29","author":"Moon","year":"2008","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.brainres.2012.11.043_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/PPA.S4084","article-title":"Levodopa\/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.brainres.2012.11.043_bib52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/dmd.32.5.497","article-title":"Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase","volume":"32","author":"Nagai","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.brainres.2012.11.043_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cne.901920209","article-title":"Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid","volume":"192","author":"Nalder","year":"1980","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2012.11.043_bib54","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/s10072-006-0546-6","article-title":"Parkinson's disease and dementia","volume":"27","author":"Padovani","year":"2006","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainres.2012.11.043_bib55","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1523\/JNEUROSCI.18-20-08236.1998","article-title":"Induction of NF-\u03baB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-\u03baB and neuroprotection by antioxidants","volume":"18","author":"Post","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2012.11.043_bib56","first-page":"94","article-title":"O-Methyldopa interferes with striatal utilization of levodopa","volume":"10","author":"Raches","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2012.11.043_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249445","article-title":"Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis","volume":"38","author":"Riederer","year":"1976","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2012.11.043_bib58","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.bjp.0702474","article-title":"In vivo effects of new inhibitors of catechol-O-methyl transferase","volume":"126","author":"Rivas","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib59","doi-asserted-by":"crossref","first-page":"2073S","DOI":"10.1093\/jn\/130.8.2073S","article-title":"Dietary intake and bioavailability of polyphenols","volume":"130","author":"Scalbert","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.brainres.2012.11.043_bib61","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.metabol.2008.03.001","article-title":"A natural history of botanical therapeutics","volume":"57","author":"Schmidt","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.brainres.2012.11.043_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2012.11.043_bib64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00002826-199712000-00005","article-title":"Effect of tolcapone on plasma levodopa concentrations after coadministration with levodopa\/carbidopa to healthy volunteers","volume":"20","author":"S\u00eadek","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2012.11.043_bib65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mds.10312","article-title":"Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease","volume":"18","author":"Segovia","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2012.11.043_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0009-8981(72)90456-1","article-title":"3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease","volume":"37","author":"Sharpless","year":"1972","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.brainres.2012.11.043_bib67","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/jnr.21880","article-title":"Protection against kainate neurotoxicity by ginsenosides: attenuation of convulsive behavior, mitochondrial dysfunction, and oxidative stress","volume":"15","author":"Shin","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2012.11.043_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1471-4159.1998.71010095.x","article-title":"Oxidative stress induces a form of programmed cell death with characteristics of both necrosis and apoptosis in neuronal cells","volume":"71","author":"Tan","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2012.11.043_bib69","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.46.5.1430","article-title":"Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET","volume":"46","author":"Tedroff","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2012.11.043_bib70","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pneurobio.2008.05.003","article-title":"Progress in Parkinson's disease\u2014Where do we stand?","volume":"85","author":"Toulouse","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2012.11.043_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3940(91)90422-P","article-title":"The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease","volume":"132","author":"Tohgi","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2012.11.043_bib72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/toxsci\/kfh216","article-title":"Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage","volume":"81","author":"van Duursen","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.brainres.2012.11.043_bib75","doi-asserted-by":"crossref","first-page":"III5","DOI":"10.1007\/PL00022917","article-title":"Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background","volume":"248","author":"Yamamoto","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2012.11.043_bib76","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0090-9556(24)15181-1","article-title":"O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase","volume":"28","author":"Zhu","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.brainres.2012.11.043_bib77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1389200023337586","article-title":"Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis","volume":"3","author":"Zhu","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.brainres.2012.11.043_bib78","first-page":"343","article-title":"CNS dopamine oxidation and catechol-O-methyltransferase (COMT): Importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease","volume":"13","author":"Zhu","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.brainres.2012.11.043_bib79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/00498250701744641","article-title":"Molecular mechanism for the high-potency inhibition of human catechol-O-methyltransferase by (\u2212)-epigallocatechin-3-O-gallate","volume":"38","author":"Zhu","year":"2008","journal-title":"Xenobiotica"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899312018379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899312018379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T01:26:22Z","timestamp":1745371582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899312018379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":71,"alternative-id":["S0006899312018379"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2012.11.043","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}